Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO Study.

[1]  C. Trani,et al.  Predictors of early discharge after transcatheter aortic valve implantation: insight from the CoreValve ClinicalService , 2022, Journal of cardiovascular medicine.

[2]  J. Rodés‐Cabau,et al.  Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR: A Propensity Score Analysis. , 2022, JACC. Cardiovascular interventions.

[3]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[4]  A. Kini,et al.  TCT-451 Thirty-Day Outcomes After Next-Day Discharge in Transcatheter Aortic Valve Replacement: Analysis of the STS/ACC TVT Registry , 2021, Journal of the American College of Cardiology.

[5]  Jeroen J. Bax,et al.  Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. , 2021, Journal of the American College of Cardiology.

[6]  M. Mack,et al.  2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.

[7]  Peter J. Neuburger,et al.  Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement. , 2019, JACC. Cardiovascular interventions.

[8]  M. Mack,et al.  Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel. , 2019, Journal of the American College of Cardiology.

[9]  C. Tamburino,et al.  Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  Andrew S. Mugglin,et al.  Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[11]  J. Leipsic,et al.  The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study. , 2019, JACC. Cardiovascular interventions.

[12]  S. Lansman,et al.  "Cusp-Overlap" View Simplifies Fluoroscopy-Guided Implantation of Self-Expanding Valve in Transcatheter Aortic Valve Replacement. , 2018, JACC. Cardiovascular interventions.

[13]  Jeroen J. Bax,et al.  Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review , 2018, European heart journal.

[14]  J. Oh,et al.  Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. , 2018, JACC. Cardiovascular interventions.

[15]  Andrew S. Mugglin,et al.  Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.

[16]  S. Kaul.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[17]  Assaf Bash,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.

[18]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.